<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/48990B2D-6D88-4205-B3F4-58863EA78D0D"><gtr:id>48990B2D-6D88-4205-B3F4-58863EA78D0D</gtr:id><gtr:name>National Institute of Health and Medical Research (INSERM)</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/6BE14EEB-8C76-4661-A42D-5BBE8B8AC5ED"><gtr:id>6BE14EEB-8C76-4661-A42D-5BBE8B8AC5ED</gtr:id><gtr:name>Technical University Dresden</gtr:name><gtr:address><gtr:line1>TU Dresden</gtr:line1><gtr:postCode>D-01062</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/102F2A51-71E4-4ECA-A245-9B9C4858D7E4"><gtr:id>102F2A51-71E4-4ECA-A245-9B9C4858D7E4</gtr:id><gtr:name>MRC Harwell</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:department>William Harvey Research Institute</gtr:department><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/48990B2D-6D88-4205-B3F4-58863EA78D0D"><gtr:id>48990B2D-6D88-4205-B3F4-58863EA78D0D</gtr:id><gtr:name>National Institute of Health and Medical Research (INSERM)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/6BE14EEB-8C76-4661-A42D-5BBE8B8AC5ED"><gtr:id>6BE14EEB-8C76-4661-A42D-5BBE8B8AC5ED</gtr:id><gtr:name>Technical University Dresden</gtr:name><gtr:address><gtr:line1>TU Dresden</gtr:line1><gtr:postCode>D-01062</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Germany</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/102F2A51-71E4-4ECA-A245-9B9C4858D7E4"><gtr:id>102F2A51-71E4-4ECA-A245-9B9C4858D7E4</gtr:id><gtr:name>MRC Harwell</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/0969A8FC-FEF3-4121-91A1-6CC10265F111"><gtr:id>0969A8FC-FEF3-4121-91A1-6CC10265F111</gtr:id><gtr:firstName>Louise</gtr:firstName><gtr:otherNames>Amanda</gtr:otherNames><gtr:surname>Metherell</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0801265"><gtr:id>4A1DAAA1-0A4C-46EC-A2E9-E34252B20641</gtr:id><gtr:title>ACTH receptor pathway defects as the cause of Familial Glucocorticoid Deficiency type 3 (FGD3)</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0801265</gtr:grantReference><gtr:abstractText>I am interested in a rare disease called Familial Glucocorticoid Deficiency (FGD). Patients with this disease do not have a mechanism to cope with stress. If their body becomes stressed, for example by illness, their blood sugar levels drop, they become liable to infections and they may die if untreated. ACTH is the hormone that is produced in response to stress and the ACTH receptor is the protein that recognises ACTH and causes the changes that help the body to cope with the stress. FGD can be caused by a defective ACTH receptor (ACTHR) in a quarter of all cases. In the other three quarters the ACTHR is normal. However we have recently discovered another gene called MRAP that also causes the disease. This gene makes a protein that is needed for the correct functioning of the ACTHR. Exactly how this mechanism works is not fully understood and we believe that other genes may also be necessary. Currently we are searching for these genes by seeing if they interact with the ACTHR and MRAP and by studying the genetic make-up of FGD patients. When we find these other genes and find out what they do we will have a better understanding of how this hormone receptor works. We hope that this knowledge may also shed light on other diseases, such as childhood obesity, that are caused by defects in similar receptor systems.</gtr:abstractText><gtr:technicalSummary>Autosomal recessive ACTH insensitivity or Familial Glucocorticoid Deficiency (OMIM #202200) is a potentially lethal disorder characterised by resistance to the action of ACTH on the adrenal cortex to stimulate glucocorticoid production. Affected individuals are therefore deficient in cortisol and if untreated are likely to succumb to hypoglycaemia in infancy or early childhood. Twenty-five percent of cases result from mutations in the ACTH receptor or melanocortin 2 receptor gene (MC2R), termed FGD type 1 (FGD1). MC2R has been difficult to express in non-adrenal cell lines, leading to the suggestion that it requires accessory factor(s) only present in the adrenal. In 2005 I described such an accessory factor (MRAP) that is absolutely necessary for correct functioning of MC2R. MRAP is co-localised with and interacts directly with the MC2R, and enables a functional receptor to be expressed. Mutations in this gene account for a further 20% of FGD cases leaving more than half of the cases with no known cause (termed FGD3). FGD3 is itself genetically heterogeneous , a recent pilot study I conducted has identified 3 new loci for FGD on chromosomes 5, 10 and 21. The fact that there exist further genetic causes of FGD with an identical phenotype to types 1 and 2, implies that MC2R and MRAP are only two parts of an interacting complex of proteins that are necessary for the correct functioning and signalling of MC2R. I now aim to identify such proteins, which are candidates for FGD3, by using two approaches. Firstly, I will seek candidates for the disease by sequencing genes within the newly identified loci in FGD3 patients, utilising new high throughput sequencing technologies. Secondly. proteins that interact will be ?pulled out? by Tandem Affinity Purification utilising dual tagged MC2R and MRAP and such proteins will be identified by Mass Spectrometry. Finding such proteins in the MC2R life-cycle may give us clues to diseases involving other melanocortin receptors such as MC4R, defects in which lead to the most common form of monogenic childhood obesity.</gtr:technicalSummary><gtr:fund><gtr:end>2013-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>495810</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute of Health and Medical Research (INSERM)</gtr:collaboratingOrganisation><gtr:country>France, French Republic</gtr:country><gtr:department>INSERM U870 (Metabolic regulation, Nutrition and Diabetes)</gtr:department><gtr:description>FGD consortium</gtr:description><gtr:id>4BC99E86-D5FE-416F-920A-A15848CC0541</gtr:id><gtr:impact>Outputs are many publications describing disease causing mutations in patients with familial glucocorticoid deficiency. This collaboration is not multi-disciplinary.</gtr:impact><gtr:outcomeId>GG5wTgngiTS-2</gtr:outcomeId><gtr:partnerContribution>Contribution of patient samplescontribution of patient samples</gtr:partnerContribution><gtr:piContribution>Discovery of novel genes responsible for cases of familial glucocorticoid deficiency</gtr:piContribution><gtr:sector>Public</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Technical University of Dresden</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>Children's Hospital</gtr:department><gtr:description>FGD consortium</gtr:description><gtr:id>005F5E74-D401-4897-A507-010931FE0646</gtr:id><gtr:impact>Outputs are many publications describing disease causing mutations in patients with familial glucocorticoid deficiency. This collaboration is not multi-disciplinary.</gtr:impact><gtr:outcomeId>GG5wTgngiTS-1</gtr:outcomeId><gtr:partnerContribution>Contribution of patient samplescontribution of patient samples</gtr:partnerContribution><gtr:piContribution>Discovery of novel genes responsible for cases of familial glucocorticoid deficiency</gtr:piContribution><gtr:sector>Hospitals</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>MRC Harwell</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Roger Cox MRC Harwell</gtr:description><gtr:id>CA9D6A61-A2F8-438A-B1EB-95587286E6E3</gtr:id><gtr:impact>Nature Genetics paper</gtr:impact><gtr:outcomeId>DA4HU8MPKjS-1</gtr:outcomeId><gtr:partnerContribution>Supply of wild-type, mutant and BAC rescued NNT mice</gtr:partnerContribution><gtr:piContribution>Adrenal histology in NNT mutant mice</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>73660</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>PhD studentship</gtr:description><gtr:end>2012-10-02</gtr:end><gtr:fundingOrg>Barts Charity</gtr:fundingOrg><gtr:id>45E45E3F-97A3-4891-80EB-62217408EBD6</gtr:id><gtr:outcomeId>jPzSVT5tf9W</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>clinical practice</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>8AE227AC-8EB0-4290-B146-5C25F3B071EF</gtr:id><gtr:outcomeId>02550DE012B</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>H295R human adrenocortical cell line with stable knockdown of glutathione peroxidase 1 (GPX1) gene, achieved by lentiviral delivery of shRNA targeting the gene.C</gtr:description><gtr:id>5134252D-A7F1-458D-9BE2-C70CBA6A8948</gtr:id><gtr:impact>Creation of this cell line has allowed us to assess the effect of knockdown of GPX1.</gtr:impact><gtr:outcomeId>ZZH5AjXxaWh</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>H295RGPX1KD</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>H295R human adrenocortical cell line with stable knockdown of nicotinamide nucleotide transhydrogenase (NNT) gene, achieved by lentiviral delivery of shRNA targeting the gene.</gtr:description><gtr:id>B72A5970-C2DD-4F3A-899C-2E364DC8F963</gtr:id><gtr:impact>Creation of this cell line has allowed us to study the effect of knockdown of NNT</gtr:impact><gtr:outcomeId>mXuEMPZ4rkk</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>H295RNNTKD</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2013</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>9B2A807E-0E0F-41ED-BD45-01D40B226B38</gtr:id><gtr:title>Homozygous nonsense and frameshift mutations of the ACTH receptor in children with familial glucocorticoid deficiency (FGD) are not associated with long-term mineralocorticoid deficiency.</gtr:title><gtr:parentPublicationTitle>Clinical endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74e15fa55925f0d3873ae267e93060ef"><gtr:id>74e15fa55925f0d3873ae267e93060ef</gtr:id><gtr:otherNames>Chan LF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0300-0664</gtr:issn><gtr:outcomeId>88850E9577F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE2DD0E5-1372-4389-8008-39E0DAA43836</gtr:id><gtr:title>MCM4 mutation causes adrenal failure, short stature, and natural killer cell deficiency in humans.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical investigation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f00f976db1ab8a325f5ad80b8f3adc7"><gtr:id>0f00f976db1ab8a325f5ad80b8f3adc7</gtr:id><gtr:otherNames>Hughes CR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-9738</gtr:issn><gtr:outcomeId>pm_14360_20_22354170</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B47A0C30-111B-4897-8A6F-1BC7E2C77907</gtr:id><gtr:title>Deficiency of ALADIN impairs redox homeostasis in human adrenal cells and inhibits steroidogenesis.</gtr:title><gtr:parentPublicationTitle>Endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6d8bd4f9629df5ee96a207d66f8e3dae"><gtr:id>6d8bd4f9629df5ee96a207d66f8e3dae</gtr:id><gtr:otherNames>Prasad R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0013-7227</gtr:issn><gtr:outcomeId>pm_14360_20_23825130</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>94E7CCB7-F44F-4D53-AA51-76DA5A1BCE03</gtr:id><gtr:title>Accessory proteins are vital for the functional expression of certain G protein-coupled receptors.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b13f565af01e8b797b5e7db33536e446"><gtr:id>b13f565af01e8b797b5e7db33536e446</gtr:id><gtr:otherNames>Cooray SN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0303-7207</gtr:issn><gtr:outcomeId>7753E01B6D6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>129FC313-20C6-456F-9930-2A8F1F995AB0</gtr:id><gtr:title>Phenotypic characteristics of familial glucocorticoid deficiency (FGD) type 1 and 2.</gtr:title><gtr:parentPublicationTitle>Clinical endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d2ca63c2242b9dacfc3a53571390c4b"><gtr:id>7d2ca63c2242b9dacfc3a53571390c4b</gtr:id><gtr:otherNames>Chung TT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0300-0664</gtr:issn><gtr:outcomeId>7BEDD3394BA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4EEF9D8E-5267-41DA-ABB7-1D0DDEA994E7</gtr:id><gtr:title>Mutations in NNT encoding nicotinamide nucleotide transhydrogenase cause familial glucocorticoid deficiency.</gtr:title><gtr:parentPublicationTitle>Nature genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70a128e7e59226a0bdc91ba2c85ca251"><gtr:id>70a128e7e59226a0bdc91ba2c85ca251</gtr:id><gtr:otherNames>Meimaridou E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1061-4036</gtr:issn><gtr:outcomeId>pm_14360_20_22634753</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A880F76F-AF09-447B-B4A4-04DC218442B4</gtr:id><gtr:title>The majority of adrenocorticotropin receptor (melanocortin 2 receptor) mutations found in familial glucocorticoid deficiency type 1 lead to defective trafficking of the receptor to the cell surface.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7d2ca63c2242b9dacfc3a53571390c4b"><gtr:id>7d2ca63c2242b9dacfc3a53571390c4b</gtr:id><gtr:otherNames>Chung TT</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>66D4D214FB2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CE769EF7-216D-4CB6-A11B-86FDC5E2345C</gtr:id><gtr:title>Adrenocorticotropin resistance syndromes.</gtr:title><gtr:parentPublicationTitle>Endocrine development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b13f565af01e8b797b5e7db33536e446"><gtr:id>b13f565af01e8b797b5e7db33536e446</gtr:id><gtr:otherNames>Cooray SN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1421-7082</gtr:issn><gtr:outcomeId>285570ED565</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2DEEF53F-A1A9-46DD-A2E0-71C9F8FB6BC9</gtr:id><gtr:title>MRAP and MRAP2 are bidirectional regulators of the melanocortin receptor family.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74e15fa55925f0d3873ae267e93060ef"><gtr:id>74e15fa55925f0d3873ae267e93060ef</gtr:id><gtr:otherNames>Chan LF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>45C1F268DE4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>07529501-64E7-4482-8986-11C97E411643</gtr:id><gtr:title>Familial glucocorticoid deficiency: a diagnostic challenge during acute illness.</gtr:title><gtr:parentPublicationTitle>European journal of pediatrics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f9cf0c2d8fc4ebe3b692524b53cbf85d"><gtr:id>f9cf0c2d8fc4ebe3b692524b53cbf85d</gtr:id><gtr:otherNames>Habeb AM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0340-6199</gtr:issn><gtr:outcomeId>pm_14360_20_23708259</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A8A616F-3CB9-4751-8512-412EE0E5CB53</gtr:id><gtr:title>Familial glucocorticoid deficiency: New genes and mechanisms.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70a128e7e59226a0bdc91ba2c85ca251"><gtr:id>70a128e7e59226a0bdc91ba2c85ca251</gtr:id><gtr:otherNames>Meimaridou E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0303-7207</gtr:issn><gtr:outcomeId>5461097a2f7ef0.99444677</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5D2AAF2-C20A-4F4F-93ED-BDAF096E82BB</gtr:id><gtr:title>Nonclassic lipoid congenital adrenal hyperplasia masquerading as familial glucocorticoid deficiency.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/efffd827f4cf03299dd1a9576ea0f846"><gtr:id>efffd827f4cf03299dd1a9576ea0f846</gtr:id><gtr:otherNames>Metherell LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>64FC825F2F4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>279288FC-1831-454C-BC66-BDD51BC1ED50</gtr:id><gtr:title>Missense mutations in the melanocortin 2 receptor accessory protein that lead to late onset familial glucocorticoid deficiency type 2.</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f00f976db1ab8a325f5ad80b8f3adc7"><gtr:id>0f00f976db1ab8a325f5ad80b8f3adc7</gtr:id><gtr:otherNames>Hughes CR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>nokWx3RBK9U</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7D1A5331-54E0-402B-8774-01E80508FD3B</gtr:id><gtr:title>Isolated Addison's disease is unlikely to be caused by mutations in MC2R, MRAP or STAR, three genes responsible for familial glucocorticoid deficiency.</gtr:title><gtr:parentPublicationTitle>European journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/bd8da0dddbb04c15088623de9bc1d323"><gtr:id>bd8da0dddbb04c15088623de9bc1d323</gtr:id><gtr:otherNames>Dias RP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0804-4643</gtr:issn><gtr:outcomeId>A77DC849AFE</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6B4170C0-80A0-4363-B078-C9D8D2C0C7FF</gtr:id><gtr:title>Effects of melanocortins on adrenal gland physiology.</gtr:title><gtr:parentPublicationTitle>European journal of pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74e15fa55925f0d3873ae267e93060ef"><gtr:id>74e15fa55925f0d3873ae267e93060ef</gtr:id><gtr:otherNames>Chan LF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0014-2999</gtr:issn><gtr:outcomeId>FTTonfgqjuV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7F3886EA-9F96-457D-A365-D85A5E3E17A0</gtr:id><gtr:title>The genetics of familial glucocorticoid deficiency.</gtr:title><gtr:parentPublicationTitle>Best practice &amp; research. Clinical endocrinology &amp; metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f1cc2aa8d2d6d1ed6ad73bf575ba1f1f"><gtr:id>f1cc2aa8d2d6d1ed6ad73bf575ba1f1f</gtr:id><gtr:otherNames>Clark AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1521-690X</gtr:issn><gtr:outcomeId>84F9E89F4FF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>12FF9F20-C308-453F-9825-A79C369E0E31</gtr:id><gtr:title>Neonatal presentation of familial glucocorticoid deficiency resulting from a novel splice mutation in the melanocortin 2 receptor accessory protein.</gtr:title><gtr:parentPublicationTitle>European journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/470ff63ab1deeff3319aa900d06a5a80"><gtr:id>470ff63ab1deeff3319aa900d06a5a80</gtr:id><gtr:otherNames>Jain V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0804-4643</gtr:issn><gtr:outcomeId>NJ7TCoAeaRk</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>594651EE-A386-4370-B3D3-80F7C1C31A1D</gtr:id><gtr:title>Functional consequence of a novel Y129C mutation in a patient with two contradictory melanocortin-2-receptor mutations.</gtr:title><gtr:parentPublicationTitle>European journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74e15fa55925f0d3873ae267e93060ef"><gtr:id>74e15fa55925f0d3873ae267e93060ef</gtr:id><gtr:otherNames>Chan LF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0804-4643</gtr:issn><gtr:outcomeId>006AB80DC54</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F561A81-1393-461E-A3F6-414B30FF7877</gtr:id><gtr:title>An atypical case of familial glucocorticoid deficiency without pigmentation caused by coexistent homozygous mutations in MC2R (T152K) and MC1R (R160W).</gtr:title><gtr:parentPublicationTitle>The Journal of clinical endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32266ebd4641ea54631223d7138501ad"><gtr:id>32266ebd4641ea54631223d7138501ad</gtr:id><gtr:otherNames>Turan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0021-972X</gtr:issn><gtr:outcomeId>pm_14360_20_22337906</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>22C8EEB2-CD94-4D20-A603-845C771C360A</gtr:id><gtr:title>Familial glucocorticoid deficiency: advances in the molecular understanding of ACTH action.</gtr:title><gtr:parentPublicationTitle>Hormone research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/74e15fa55925f0d3873ae267e93060ef"><gtr:id>74e15fa55925f0d3873ae267e93060ef</gtr:id><gtr:otherNames>Chan LF</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0301-0163</gtr:issn><gtr:outcomeId>40D03173DEF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BCF2180C-FE1F-4415-883F-7A4C8A0604E5</gtr:id><gtr:title>ACTH resistance: genes and mechanisms.</gtr:title><gtr:parentPublicationTitle>Endocrine development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/70a128e7e59226a0bdc91ba2c85ca251"><gtr:id>70a128e7e59226a0bdc91ba2c85ca251</gtr:id><gtr:otherNames>Meimaridou E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1421-7082</gtr:issn><gtr:outcomeId>pm_14360_20_23392095</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0801265</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>